Canopy Growth Corporation
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- -
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
Phase 1
Completed
- Conditions
- Healthy Adults
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 301
- Registration Number
- NCT05839964
- Locations
- 🇺🇸
Remote, Fayetteville, Arkansas, United States
The Effects of CBD Isolate on Menstrual-Related Symptoms
- First Posted Date
- 2023-01-11
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT05679830
- Locations
- 🇺🇸
James Madison University, Harrisonburg, Virginia, United States
CBD in Postmenopausal Women With Osteopenia
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT05317013
- Locations
- 🇺🇸
NM Clinical Research & Osteoporosis Center, Inc., Albuquerque, New Mexico, United States
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy Adults
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT05210634
- Locations
- 🇺🇸
Nucleus Network, Saint Paul, Minnesota, United States
Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity
Phase 2
Completed
- Conditions
- Delayed Onset Muscle Soreness (DOMS)
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT05026164
- Locations
- 🇺🇸
International Society for Sports Nutrition, Boca Raton, Florida, United States
Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain
- Conditions
- Chronic Pain
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT04763252
- Locations
- 🇨🇦
Burrard Pain Doctors, Vancouver, British Columbia, Canada
A Randomized Controlled Test of the Effects of CHI-554 on Fear.
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 84
- Registration Number
- NCT04577612
- Locations
- 🇺🇸
Ellen W Leen-Feldner, University of Arkansas, Fayetteville, Arkansas, United States
CHI-907 CBD Extract and Experiences of Test Anxiety
Phase 2
Terminated
- Conditions
- Anxiety
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT04269252
- Locations
- 🇺🇸
James Madison University, Harrisonburg, Virginia, United States
CHI-902 for Treatment of Social Anxiety Disorder
Phase 2
Withdrawn
- Conditions
- Social Anxiety Disorder
- Interventions
- Drug: PlaceboDrug: CHI-902
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Canopy Growth Corporation
- Registration Number
- NCT04086342
- Locations
- 🇨🇦
MacAnxiety Research Center, McMaster University, Hamilton, Ontario, Canada
🇨🇦Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada
Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
- First Posted Date
- 2019-06-13
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Canopy Growth Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT03984604
- Locations
- 🇨🇦
Algorithme Pharma Inc., Montréal, Quebec, Canada